Dr Ken Harvey is a public health physician and consumer advocate with expertise in medicines policy. Dr Harvey currently represents Choice on the Therapeutic Goods Advertising Consultative Council, is President of Friends of Science in Medicine and an Associate Professor in the School of Public Health and Preventive Medicine, Monash University.
Just two years on from the implementation of new laws to control advertising for misleading and deceptive therapeutic goods, the scheme is in tatters. Having failed to halt a wave of wrongful conduct and in the face of growing numbers of complaints the TGA has given up on systematic enforcement…. Continue reading »
Almost 2 years after complaints about numerous hangover products were submitted to the TGA they have finally published one outcome. The TGA agreed there was insufficient evidence to support claims related to hangover relief…. Continue reading »
Dr Ken Harvey has provided the following formal response from the TGA as an update to his article (Pearls and Irritations, 7 May, https://johnmenadue.com/ken-harvey-tga-fails-to-act-on-palmers-hydroxychloroquine-advertisements/)… Continue reading »
The recent decision by the Therapeutic Goods Administration (TGA) to drop its investigation into advertisements for hydroxychloroquine splashed over 3 pages of national newspapers by Clive Palmer is the latest example of its regulatory failure…. Continue reading »
On 3 February 2018 Health Minister Hunt stated, “the TGA will be adequately resourced and staffed to manage complaints from July 1, 2018”. Instead, during 2018-19, 74 TGA staff positions were lost to boost the government’s Aged Care initiatives in a government zero sum game, presumably to assist the desired budget surplus. Consequently, of 121… Continue reading »